Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study
Clinical trial NCT04536532 · TERMINATED
Trial details
- NCT number
- NCT04536532
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-09
- Primary completion
- 2023-03-12
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.